Search For "mild"
Kate Middleton prepared for her future role as Queen
Updated : 5 years, 2 months ago IST
London [UK], January 9 (ANI): As she turned 39 years old on Saturday, it became apparent that the Duchess of Cambridge, Kate Middleton, who was once merely a mild-mannered college graduate, is ready for her role as the future Queen.
Read More
Equity indices close in red, Nestle drops 2 pc
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], January 7 (ANI): Equity benchmark indices turned volatile in the last hour of trade on Thursday and closed with mild losses.
Read More
Covid-19: Bulgaria reports 4 cases of side effects from Pfizer/BioNTech va
Updated : 5 years, 2 months ago IST
Sofia [Bulgaria], January 4 (ANI/Sputnik): Four Bulgarians vaccinated against Covid-19 with the Pfizer/BioNTech vaccine developed mild to moderate side effects, Bulgarian Drug Agency executive director Bogdan Kirilov said on Monday.
Read More
Argentina reports adverse reaction to Sputnik V vaccine in 1pc of inoculat
Updated : 5 years, 2 months ago IST
Buenos Aires [Argentina], January 3 (ANI/Sputnik): Only 1 per cent of Argentinian citizens, who received the Russia-developed Sputnik V vaccine against the coronavirus, has shown a mild adverse reaction to the shot, the TN broadcaster reported on Saturday, citing the country's Health Ministr
Read More
COVID-19 severity is affected by proportion of antibodies targeting crucia
Updated : 5 years, 2 months ago IST
Washington [US], December 27 (ANI): Coronavirus antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases than in comparison to severe ones, suggest the findings of a new study.
Read More
Study reveals COVID-19 severity is affected by proportion of antibodies ta
Updated : 5 years, 2 months ago IST
Washington [US], December 25 (ANI): A recent study has revealed that COVID-19 antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases of COVID-19 than in comparison to severe ones.
Read More
Equity indices close in the green, energy stocks gain
Updated : 5 years, 3 months ago IST
Mumbai (Maharashtra) [India], Dec 14 (ANI): Equity benchmark indices traded with mild gains on Monday with energy stocks witnessing handsome profits.
Read More
Here's how cocoa flavanols boost brain oxygenation, cognition in healthy a
Updated : 5 years, 3 months ago IST
Washington [US], November 29 (ANI): In a recent study, researchers have found that the brains of healthy adults recovered faster from a mild vascular challenge and performed better on complex tests if the participants consumed cocoa flavanols beforehand.
Read More
Cocoa flavanols boost brain oxygenation, cognition in healthy adults
Updated : 5 years, 3 months ago IST
Washington [US], November 24 (ANI): The brains of healthy adults recovered faster from a mild vascular challenge and performed better on complex tests if the participants consumed cocoa flavanols beforehand, researchers report in the journal Scientific Reports.
Read More
Recently published data on Favipiravir as treatment for mild to moderate C
Updated : 5 years, 3 months ago IST
Mumbai (Maharashtra) [India], November 23 (ANI/PRNewswire): The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
Read More
AIMIM, BJP party workers scuffle in Hyderabad over flood relief assistance
Updated : 5 years, 4 months ago IST
Hyderabad (Telangana) [India], November 13 (ANI): Mild tension prevailed in Lal Darwaza area of Hyderabad on Thursday morning after a scuffle between party workers of BJP and AIMIM regarding the distribution of flood relief assistance.
Read More
US allows emergency use of Eli Lilly's COVID-19 antibody treatment
Updated : 5 years, 4 months ago IST
Washington DC [US], November 10 (ANI): The US Food and Drug Administration (FDA) has approved an emergency use authorisation (EUA) for American pharmaceutical company Eli Lilly's experimental COVID-19 antibody treatment called 'bamlanivimab' for non-hospitalised patients with mild-to-moderat
Read More